Insights

High-growth niche Target Evercrisp Biosciences as a biotech startup focused on hard-to-reach tissues with self-delivering miniproteins, signaling a potential need for specialized contract development, collaboration, or pilot programs to advance delivery technologies.

Targeted therapeutic delivery Opportunity to offer specialized services or partnerships around non-viral, tissue-specific delivery platforms, potentially reducing reliance on LNPs or viral vectors for genetic therapies.

Early-stage revenue Currently in revenue range of one to ten million, indicating a growing business that may be open to strategic partnerships, licensing deals, or joint development arrangements to accelerate product timelines.

Berkeley innovation hub Located in Berkeley with access to top-tier research ecosystems; potential for co-development spaces, academic collaborations, or government grant support to scale R&D activities.

Tech-first differentiation Proprietary miniprotein delivery platform offers a differentiator from conventional gene therapy delivery methods, presenting opportunities for sponsored research, pilot studies, and technology licensing discussions.

Evercrisp Biosciences Tech Stack

Evercrisp Biosciences uses 8 technology products and services including html5media, gstatic.com, WordPress, and more. Explore Evercrisp Biosciences's tech stack below.

  • html5media
    Audio, Video, Graphics
  • gstatic.com
    Content Delivery Network
  • WordPress
    Content Management System
  • jQuery
    Javascript Libraries
  • Really Simple Discovery
    Miscellaneous
  • Box
    Team Collaboration
  • GoDaddy
    Web Hosting
  • Apache HTTP Server
    Web Servers

Media & News

Evercrisp Biosciences's Email Address Formats

Evercrisp Biosciences uses at least 2 format(s):
Evercrisp Biosciences Email FormatsExamplePercentage
FLast@evercrispbiosciences.comJDoe@evercrispbiosciences.com
89%
First@evercrispbiosciences.comJohn@evercrispbiosciences.com
11%
FLast@evercrispbio.comJDoe@evercrispbio.com
100%

Frequently Asked Questions

What is Evercrisp Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Evercrisp Biosciences's official website is evercrispbio.com and has social profiles on LinkedIn.

What is Evercrisp Biosciences's SIC code NAICS code?

Minus sign iconPlus sign icon
Evercrisp Biosciences's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evercrisp Biosciences have currently?

Minus sign iconPlus sign icon
As of July 2026, Evercrisp Biosciences has approximately 17 employees across 2 continents, including North AmericaSouth America. Key team members include Senior Scientist: P. Z.Associate Scientist: C. A.. Explore Evercrisp Biosciences's employee directory with LeadIQ.

What industry does Evercrisp Biosciences belong to?

Minus sign iconPlus sign icon
Evercrisp Biosciences operates in the Biotechnology Research industry.

What technology does Evercrisp Biosciences use?

Minus sign iconPlus sign icon
Evercrisp Biosciences's tech stack includes html5mediagstatic.comWordPressjQueryReally Simple DiscoveryBoxGoDaddyApache HTTP Server.

What is Evercrisp Biosciences's email format?

Minus sign iconPlus sign icon
Evercrisp Biosciences's email format typically follows the pattern of FLast@evercrispbiosciences.com. Find more Evercrisp Biosciences email formats with LeadIQ.

When was Evercrisp Biosciences founded?

Minus sign iconPlus sign icon
Evercrisp Biosciences was founded in 2021.
Evercrisp Biosciences logo

Evercrisp Biosciences

Biotechnology ResearchCalifornia, United States11-50 Employees

Evercrisp Biosciences is a biotechnology research company focused on developing delivery methods for genetic therapies. Its work aims to enable precise, safe, and scalable delivery into tissues such as the brain, kidney, and muscle, using proprietary approaches to create miniproteins that can access areas previously unreachable by genetic medicines. These self-delivering miniproteins are designed to function without auxiliary delivery vehicles that can provoke immune responses, addressing a key challenge in delivering genetic therapies. The company is based in Berkeley, California, and operates within the biotechnology research sector, seeking to serve researchers and developers pursuing advanced genetic medicine delivery solutions. With a relatively small and specialized team, Evercrisp emphasizes its foundational science drawn from experienced scientific founders to support its development efforts. A recent development highlight indicates ongoing progress in advancing its delivery capabilities for targeted tissues.” } } { } { } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Evercrisp Biosciences's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Evercrisp Biosciences's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.